Modular systems are becoming increasingly important in specialty machine manufacture. The INOVA SV125 exhibited has been further developed into a proven, modular filling and closing machine system. The INOVA SV is suitable for processes from pilot testing to medium output manufacturing. A maximum output of 18,000 containers / hour is achieved via ten filling points, with a dosing range of 0.1 to 50 ml. The system boasts impressive flexibility.
Optima Life Science will be presenting three exhibits at CompaMed, the core of which is the MEDICON ImmuCoat® production line, a modular, scalable system for the automatic coating of microplates for the production of ELISA test kits. The key feature: all base modules can also be combined as desired for true “plug & play” convenience.
Optima – a leading manufacturer of packaging lines – is exhibiting the very latest service technologies at Pack Expo. The central constituent part of "TCAM" (Total Care Asset Management) is TCAP (Total Care Asset Package), the Condition Monitoring System of Optima. The state of the machine is monitored constantly by means of electronics and sensors. A warning is given automatically even before errors occur.
Optima Pharma is a vendor of leading-edge filling, closing and process technologies for sterile and non-sterile medications. At Pharma Expo the company is exhibiting a compact machine with a three-way function in the form of the INOVA EKCS: In addition to labelling, plungers are inserted into syringes and finger grips installed.
Optima will be exhibiting its intelligent process and packaging solutions at the upcoming Interpack trade fair, where the focus will be on flexibility, high outputs and line solutions to offer users the best possible return on investment. A number of important new developments will be showcased. An overview follows below.
The 46-year-old mechanical engineer and MBA graduate brings with him many years of international experience in the pump, plant engineering and process industries.
As of January 2014, Stephan Reuter (44) is the new Managing Director of OPTIMA pharma GmbH in Mornshausen, a worldwide known manufacturer of high quality innovative freeze-drying systems for the pharmaceutical and biotechnology industries.
Hans Bhler (Managing Director Optima Group), Roland P. Wilhelm (Architect), Rainer Feuchter (Managing Director S.F. Vision, GF Kugler und Stern), Hermann-Josef Pelgrim (Mayor City Schwaebisch Hall), Matthias Dietz (Facility Manager Optima Group, Rolf Blank (Engineering company Blank), Martin Sauter (Sales Director Optima Consumer), Michael Knaus (First Provincial Official of the County Schwaebsich Hall)
Great interest in the new styleguide - all employees worldwide receive the corporate design information Following rapid growth in the past years, Optima accentuates the unity of the company with a new corporate design.
The Optima Group will roll out its# new image worldwide. #We want to present ourselves with the single brand Optima in the future#, explains the company president Hans Bhler. #We are one company, have one spirit, and speak one language#. That should be made visible. The most obvious change is the new company logo which focuses on the essentials: it is easily legible, and succinct. The wordmark appears in bright blue and stands as the corporate brand for all Optima worldwide. As of January 1st, 2012, the new design will be successively implemented. #We#ll begin with the primary communication methods, converting the homepage, letterhead, and business cards to the new format. The remaining conversions will take place later in the year, at our trade show presence and with our machine labeling; Optima worldwide will change to the new design#, explains Marketing Director Sabine Gauger. #We want to further strengthen the Optima brand worldwide#.
Outstanding technical details on turnkey lines distinguish Optima's equipment for filling, closing and packaging of pharmaceutical products. Isolators, freeze dryers, flexible and compact machines as well as equipment for diagnostics are all included in the product range.
A complete Optima line for vials encompasses all process steps from unpacking to tray loading of processed vials. Isolators and the freeze drying process are also components of the line. Numerous customized solutions have been integrated. A 100% IPC and the stopper re-setting process maximize product usage. The M+P isolator uses H2O2 to sterilize the machine cabin. With the use of catalytic aeration, considerably shorter sterilization cycle times can be achieved. When in production the isolator operates at an ISO 5 environment. Never leaving laminar flow areas, vials are transferred via a turntable to one of 6 Klee freeze dryers to achieve the most flexible loading configurations. The same path is followed by conventionally stoppered vials. A combination crimp cap and coding machine and final tray loading complete the Optima equipment. Processes are monitored by numerous optical inspections, while the environment is continuously monitored for the presence of airborne particles and viable organisms. Outside of the isolator, a disposable product path provides an assured product path sterility and zero risk of cross contamination.
With the use of catalytic aeration, M+P is able to reduce the duration of the aeration phase in isolators by more than 50%. The aeration phase is the most time consuming process in the decontamination of isolators used for pharmaceutical filling and closing equipment. Decontamination with VHP (Vaporous Hydrogen Pyroxide) regularly takes place prior to production. Existing M+P isolators can also benefit from this with a simple upgrade. The system, for which a patent has been applied, will have its' public debut at Achema 2012 at Optima Pharma (Hall 3.0, Booth A73)
Isolators are considered to be the safest method for guaranteeing a sterile filling environment in pharmaceutical production. Decontamination of isolators with vaporous H2O2 takes place in 3 process steps, which begins with the conditioning of the temperature and humidity. Next follows the sterilization phase, in which a vaporized H2O2 fog kills off any viable microbes. Even in low concentrations, H2O2 can be detrimental to pharmaceutical products, so the final phase, aeration with fresh air, must be complete. Without the use of catalytic aeration, and depending on the allowable residual concentrations (usually) 1ppm - 10ppb; largely dependent on the product), the average time required for aeration is between 3 and 12 hours. Using catalytic aeration, the aeration phase can be shortened by more than 50%.